Breakingviews: Bayer can pay more for cancer-busting Algeta
Tuesday, November 26, 2013 - 05:37
Nov. 26 - Bayer has offered to pay $2.4 bln for Norway's Algeta, a 27% premium to the stock's last close. But Breakingviews says Algeta’s cancer drug has huge potential and Bayer can afford to pay more.
▲ Hide Transcript
▶ View Transcript
Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code